Bristol Myers Price To Operating Cash Flows Ratio Over Time
| BMY Stock | USD 58.78 0.09 0.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bristol Myers Performance and Bristol Myers Correlation. Bristol |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.36) | Dividend Share 2.4 | Earnings Share (3.58) | Revenue Per Share 23.41 | Quarterly Revenue Growth 0.084 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Operating Cash Flows Ratio Analysis
Compare Bristol Myers Squibb and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Price To Operating Cash Flows Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPR | (16.5787) | (4.4159) | (11.3702) | (5.5549) | 45.7599 | (4.5131) | (3.1228) | (2.5751) | (0.869) | (0.6964) | (5.3118) | (4.0247) | 19.2761 | (5.1158) | (5.37) |
| SLNO | (1.5548) | (1.5548) | (1.5548) | (6.1411) | (0.4225) | (1.6931) | (0.9306) | (1.6241) | (3.0701) | (5.7772) | (4.7914) | (1.1777) | (0.8001) | (26.6162) | (25.29) |
| BPTH | (352) | (16.3886) | (10.4149) | (123) | (62.211) | (22.4215) | (15.359) | (2.5653) | (0.3412) | (2.5391) | (1.2285) | (2.5565) | (0.7275) | (0.3837) | (0.4) |
| MBRX | (107) | (107) | (107) | (107) | (107) | (107) | (5.9514) | (4.7158) | (2.2077) | (2.1668) | (2.6497) | (2.6378) | (1.097) | (1.0558) | (1.11) |
| CRNX | (62.208) | (62.208) | (62.208) | (62.208) | (62.208) | (62.208) | (62.208) | (35.885) | (18.7131) | (13.0776) | (6.9264) | (12.3264) | (8.2572) | (12.4238) | (13.04) |
| ASMB | (7.6876) | (36.862) | (15.4292) | (49.9547) | (44.0868) | (75.6858) | (72.0031) | 5.2 K | (95.2812) | (102) | (45.7574) | (13.9312) | (0.7451) | 1.9804 | 1.88 |
| TIL | (640) | (640) | (640) | (640) | (640) | (640) | (640) | (640) | (640) | (640) | (114) | (18.0752) | (0.4529) | (0.6042) | (0.63) |
| CTMX | (56.26) | (56.26) | (56.26) | (56.26) | 14.1667 | (6.5432) | (196) | 4.6051 | (8.3306) | (2.6818) | 57.4736 | (2.3335) | (0.9494) | (2.0416) | (2.14) |
| ACHL | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.2 K) | (1.9215) | (26.6232) | (2.4216) | (0.5917) | (0.7335) | (0.77) |
Bristol Myers Squibb and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Price To Operating Cash Flows Ratio description
My Equities
My Current Equities and Potential Positions
| Bristol Myers Squibb | BMY |
| Classification | Compulsion |
| Location | New York; U.S.A |
| Exchange | New York Stock Exchange |
USD 58.78
Additional Tools for Bristol Stock Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.